Name | 5-(N,N-Dibenzylglycyl)salicylamide |
Synonyms | 5-N,N-Dibenzylglycyl Labetalol Impurity 2 Labetalol Impurity 1 5-(N,N-Dibenzylglcyl)salicylamide 5-(N,N-DIBENZYLGLYCYL)SALICYLAMIDE 5-(N,N-Dibenzylglycyl)salicylamide 5-(N,N-Dibenzylacetyl)Salicylamide 5-(N,N-dibenzylamino)acetylsalicylamide 5-(N,N-dibenzylglycyl)-2-hydroxybenzamide benzamide, 5-[2-[bis(phenylmethyl)amino]acetyl]-2-hydroxy- N,N-dibenzyl-2-(3-carbamoyl-4-hydroxyphenyl)-2-oxoethanaminium |
CAS | 30566-92-8 |
EINECS | 250-244-9 |
InChI | InChI=1/C23H22N2O3/c24-23(28)20-13-19(11-12-21(20)26)22(27)16-25(14-17-7-3-1-4-8-17)15-18-9-5-2-6-10-18/h1-13,26H,14-16H2,(H2,24,28)/p+1 |
Molecular Formula | C23H22N2O3 |
Molar Mass | 374.43 |
Density | 1.2085 (rough estimate) |
Melting Point | 168 °C |
Boling Point | 503.44°C (rough estimate) |
Flash Point | 298.7°C |
Vapor Presure | 1.31E-13mmHg at 25°C |
pKa | 6.27±0.20(Predicted) |
Refractive Index | 1.6300 (estimate) |
Use | Used as an intermediate of the cardiovascular drug labenolol (sulfamethoxazole) |
Safety Description | 24/25 - Avoid contact with skin and eyes. |
Use | Used as an intermediate for the cardiovascular drug Rabenol (liubenzyl) Organic intermediate. |